Back to Search

JACOB LEVIN, MD

MD

Cardiovascular Disease Physician

NPI: 1053390070Individual

Specialties, Licenses & Credentials

Cardiovascular Disease PhysicianPrimary

Internal Medicine — Cardiovascular Disease

Code: 207RC0000X

25MA04287700(NJ)MD030432E(PA)

Research & Publications (20)

Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.
PMID 16426848·Bioorg Med Chem Lett·2006
7-preclinical
Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.
PMID 16084720·Bioorg Med Chem Lett·2005
7-preclinical
Benzodiazepine inhibitors of the MMPs and TACE. Part 2.
PMID 15261259·Bioorg Med Chem Lett·2004
7-preclinical
The design and synthesis of aryl hydroxamic acid inhibitors of MMPs and TACE.
PMID 15320727·Curr Top Med Chem·2004
6-review
Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.
PMID 12873518·Bioorg Med Chem Lett·2003
8-other
Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.
PMID 11934588·Bioorg Med Chem Lett·2002
8-other
Using in silico biology to facilitate drug development.
PMID 12539958·Novartis Found Symp·2002
6-review
The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.
PMID 11677139·Bioorg Med Chem Lett·2001
7-preclinical
The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.
PMID 11206467·Bioorg Med Chem Lett·2001
7-preclinical
Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.
PMID 11206468·Bioorg Med Chem Lett·2001
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1 E NEW YORK AVE, MOB 2ND FLOOR
SOMERS POINT, NJ 08244

Quick Facts

NPI
1053390070
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile